Label-Free Raman Spectral Imaging of Intracellular Delivery and Degradation of Polymeric Nanoparticle Systems

被引:107
作者
Chernenko, Tatyana [1 ]
Matthaeus, Christian [1 ]
Milane, Lara [2 ]
Quintero, Luis [3 ]
Amiji, Mansoor [2 ]
Diem, Max [3 ]
机构
[1] Northeastern Univ, Dept Chem & Biol Chem, Boston, MA 02115 USA
[2] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Boston, MA 02115 USA
[3] Univ Puerto Rico, Coll Engn, Mayaguez, PR 00680 USA
基金
美国国家科学基金会;
关键词
biodegradable nanoparticles; drug delivery systems; cells; Raman imaging; GLYCOL)-MODIFIED GELATIN NANOPARTICLES; POLY(EPSILON-CAPROLACTONE) NANOPARTICLES; ENZYMATIC DEGRADATION; TARGETED DELIVERY; QUANTUM DOTS; IN-VITRO; SPECTROSCOPY; BLENDS; TUMORS; DRUGS;
D O I
10.1021/nn9010973
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Novel optical imaging methods, such as Raman microspectroscopy, have been gaining recognition in their ability to obtain noninvasively the distribution of biochemical components of a sample. Raman spectroscopy in combination with optical microscopy provides a label-free method to assess and image cellular processes, without the use of extrinsic fluorescent dyes. The submicrometer resolution of the confocal Raman instrumentation allows us to image cellular organelles on the scale of conventional microscopy. We used the technique to monitor subcellular degradation patterns of two biodegradable nanocarrier systems-poly(E-caprolactone) (PCL) and poly(lactic-co-glycolic acid) (PLGA). Our results suggest that both drug-delivery systems eventually are incorporated into Golgi-associated vesicles of late endosomes. These processes were monitored via the decrease of the molecule-characteristic peaks of PCL and PLGA. As the catabolic pathways proceed, shifts and variations in peak intensities and intensity ratios in the rendered Raman spectra unequivocally delineate their degradation patterns.
引用
收藏
页码:3552 / 3559
页数:8
相关论文
共 49 条
[1]
Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects [J].
Cai, WB ;
Shin, DW ;
Chen, K ;
Gheysens, O ;
Cao, QZ ;
Wang, SX ;
Gambhir, SS ;
Chen, XY .
NANO LETTERS, 2006, 6 (04) :669-676
[2]
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells [J].
Cartiera, Malgorzata S. ;
Johnson, Katherine M. ;
Rajendran, Vanathy ;
Caplan, Michael J. ;
Saltzman, W. Mark .
BIOMATERIALS, 2009, 30 (14) :2790-2798
[3]
Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen [J].
Chawla, JS ;
Amiji, MM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) :127-138
[4]
Nanoparticles for nasal vaccination [J].
Csaba, Noemi ;
Garcia-Fuentes, Marcos ;
Alonso, Maria Jose .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (02) :140-157
[5]
DIEM M, 2009, INFRARED RAMAN SPECT, V17, P3
[6]
Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy [J].
Ellis, David I. ;
Goodacre, Royston .
ANALYST, 2006, 131 (08) :875-885
[7]
Enzymatic degradation of poly(ε-caprolactone)/poly(DL-lactide) blends in phosphate buffer solution [J].
Gan, ZH ;
Yu, DH ;
Zhong, ZY ;
Liang, QZ ;
Jing, XB .
POLYMER, 1999, 40 (10) :2859-2862
[8]
HINMAN LM, 1993, CANCER RES, V53, P3336
[9]
Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery [J].
Kaul, G ;
Amiji, M .
PHARMACEUTICAL RESEARCH, 2002, 19 (07) :1061-1067
[10]
Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles:: In vitro and in vivo studies [J].
Kaul, G ;
Amiji, M .
PHARMACEUTICAL RESEARCH, 2005, 22 (06) :951-961